Insiders Viridian Therapeutics, Inc.

Equities

VRDN

US92790C1045

Market Closed - Nasdaq Other stock markets 16:00:00 2024-05-10 EDT			5-day change	1st Jan Change
13.9 ^USD	-0.07%		-9.74%	-36.18%

05-09	Oppenheimer Adjusts Viridian Therapeutics Price Target to $31 From $36, Maintains Outperform Rating	MT
05-09	B. Riley Downgrades Viridian Therapeutics to Neutral From Buy	MT

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Foghorn Therapeutics Names Kristian Humer CFO	04-16	MT
Viridian Therapeutics Names Jennifer Tousignant as Chief Legal Officer	02-16	MT
Viridian Therapeutics, Inc. Appoints Jennifer Tousignant as Chief Legal Officer	02-16	CI
Viridian Therapeutics, Inc. Announces Executive Changes	01-08	CI
Viridian Therapeutics, Inc. Announces the Resignation of Scott Myers as a Member of the Board of Directors	11-02	CI
Viridian Therapeutics Names Stephen Mahoney Chief Executive	23-10-30	MT
Viridian Therapeutics, Inc. Appoints Thomas Beetham as Chief Operating Officer	23-10-30	CI
Viridian Therapeutics, Inc. Announces Management Changes	23-10-30	CI
Viridian Therapeutics, Inc. Appoints Stephen Mahoney as Chief Executive Officer	23-10-30	CI
Viridian Therapeutics, Inc. Appoints Sarah Gheuens to its Board of Directors	23-09-25	CI
Viridian Therapeutics, Inc. Announces Resignation of Kristian Humer as Chief Financial Officer	23-09-12	CI
Viridian Therapeutics, Inc. Announces Executive Changes	23-09-12	CI
Insider Buy: Viridian Therapeutics, Inc.de	23-04-13	MT
Viridian Therapeutics, Inc. Announces Appointment of Tony Casciano as Chief Commercial Officer	23-04-12	CI
Viridian Therapeutics, Inc. Announces That Carrie Melvin Has Ceased to Serve as the Company’s Chief Operating Officer	23-04-12	CI
French Biotech Sensorion Appoints Interim Chair	23-03-31	MT
Insider Buy: Viridian Therapeutics	23-03-13	MT
Viridian Therapeutics Names New Chief Executive	23-02-06	MT
Viridian Therapeutics, Inc. Appoints Scott Myers as President and Member of the Board of Directors	23-02-06	CI
Viridian Therapeutics, Inc. Appoints Scott Myers as Chief Executive Officer	23-02-06	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Viridian Therapeutics, Inc.

Equities

VRDN

US92790C1045

Insiders

Filters